Hypera

Hypera ROE

The Return on Equity (ROE) of Hypera (HYPE3.SA) as of Oct 11, 2026 is 9.55 %. In the previous year, Return on Equity (ROE) was 11.09 % — a change of -13.89% (lower).

ROE

9.55 %

YoY

-13.89%

Last updated:

In 2025, Hypera's return on equity (ROE) was 9.55 %, a -13.89% increase from the 11.09 % ROE in the previous year.

The Hypera ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
13.66 BRL
Jan 1, 2019
13.36 BRL
Jan 1, 2020
14.02 BRL
Jan 1, 2021
13.54 BRL
Jan 1, 2022
15.94 BRL
Jan 1, 2023
2.80 BRL
Jan 1, 2024
11.09 BRL
Jan 1, 2025
9.55 BRL
The Hypera ROE history
YEARROEYoY
9.55 %-13.89%
11.09 %+296.25%
2.80 %-82.45%
15.94 %+17.74%
13.54 %-3.41%
14.02 %+4.87%
13.36 %-2.19%
13.66 %+9.56%
12.47 %-6.71%
13.37 %+91.73%
6.97 %+29.43%
5.39 %—
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

ROE Details

Decoding Hypera's Return on Equity (ROE)

Hypera's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Hypera's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Hypera's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Hypera’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Hypera stock

Return on Equity (ROE) of Hypera is 9.55 % in 2025.

Return on Equity (ROE) of Hypera changed from 11.09 % to 9.55 %, representing a -13.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Hypera since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Hypera with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Hypera

All Key Metrics — Hypera